EPISODE · Jun 3, 2026 · 5 MIN
First-in-Class HEOR Challenges and Regulatory Framework Shifts
Episode 20 — 03 June 2026 Multiple first-in-class therapies create new HEOR value demonstration challenges while industry increasingly funds academic research to support policy positions. EMA's annual report reveals optimization of medicines assessments and HTA regulation coordination progress. Hosted by Marcus and Sara. Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape. Full transcript and sources at outcomes-analytica.no/podcast
Embed this episode
Ready to play
First-in-Class HEOR Challenges and Regulatory Framework Shifts
No transcript for this episode yet
Similar Episodes
No similar episodes found.